◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › BDMD

Baird Medical Investment Holdings Limited (BDMD) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Devices · DATA UPDATED 2026-07-15

Baird Medical Investment Holdings Limited (BDMD) operates in the Medical Devices industry and is headquartered in Guangzhou, China with about 146 employees. Its market capitalization is roughly $35 million. In the fiscal year ended 2025-12-31, BDMD reported $22M in revenue and ($27M) in net income.

Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China.

Interactive charts & full statements → Open the BDMD valuation workbench →

BDMD Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$22M$37M$32M$35M
Gross Profit$19M$33M$27M$28M
Operating Income (EBIT)($26M)$15M$13M$15M
Net Income($27M)$12M$10M$13M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BDMD Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-312021-12-31
Dividends Paid$0M($5M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BDMD Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$70M$78M$57M$43M
Total Liabilities$38M$38M$21M$17M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BDMD viewer.

Other Companies in Medical Devices

← BDJAll stocksBDN →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.